Results 31 to 40 of about 381,169 (335)

Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye

open access: yesPharmaceutics, 2022
Eye drops are the most common and convenient route of topical administration and the first choice of treatment for many ocular diseases. However, the ocular bioavailability of traditional eye drops (i.e., solutions, suspensions, and ointments) is very ...
Yaru Wang, Changhong Wang
doaj   +1 more source

Selenium compound protects corneal epithelium against oxidative stress. [PDF]

open access: yesPLoS ONE, 2012
The ocular surface is strongly affected by oxidative stress, and anti-oxidative systems are maintained in corneal epithelial cells and tear fluid. Dry eye is recognized as an oxidative stress-induced disease.
Akihiro Higuchi   +4 more
doaj   +1 more source

Long-Term Results after DMEK (Descemet’s Membrane Endothelial Keratoplasty) [PDF]

open access: yes, 2020
Ziel der Arbeit: Evaluation der langfristigen Ergebnisse sowie der Komplikationsrate nach Descemet’s Membran Endothelialen Keratoplastik (DMEK) Methoden: Eine cross-sectional, Fall-Serien Studie.
Wardeh, Rima
core   +1 more source

Autologous serum eye drops for dry eye [PDF]

open access: yes, 2013
=Theoretically, autologous serum eye drops (AS) have a potential advantage over traditional therapies based on the assumption that ASserve not only as a lacrimal substitute to provide lubrication, but also contain other biochemical components mimicking natural tears more closely.
Qing, Pan   +7 more
openaire   +2 more sources

Relevance of Lipid-Based Products in the Management of Dry Eye Disease [PDF]

open access: yes, 2017
Components of the ocular surface synergistically contribute to maintaining and protecting a smooth refractive layer to facilitate the optimal transmission of light.
Amrane, Mourad   +4 more
core   +1 more source

Patient-reported outcomes measures and patient preferences for minimally invasive glaucoma surgical devices. [PDF]

open access: yes, 2020
BackgroundMany therapeutic options are available to glaucoma patients. One recent therapeutic option is minimally invasive glaucoma surgical (MIGS) devices. It is unclear how patients view different treatments and which patient-reported outcomes would be
George Spaeth   +17 more
core   +1 more source

Ophthalmic Outcome in a Belgian Cohort of Cystinosis Patients Treated with a Compounded Preparation of Cysteamine Eye Drops: Retrospective Analysis

open access: yesOphthalmology and Therapy, 2019
Introduction Treatment of the anterior segment problems in cystinosis is challenging as oral cysteamine is ineffective in the treatment of corneal problems because of its avascular structure.
Freya Peeters   +5 more
doaj   +1 more source

The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 (Sod1) Knockout Mice Treated with Antiglaucoma Eye Medications

open access: yesDiagnostics, 2020
Anti-glaucoma eye drop treatment often induces dry eyes and can lead to poor medication adherence. This study aimed to investigate the effects of 3% diquafosol sodium eye drops on tear function and the ocular surface epithelium in Sod1−/− ...
Yukari Yagi-Yaguchi   +7 more
doaj   +1 more source

Current trends among pediatric ophthalmologists to decrease myopia progression—an international perspective [PDF]

open access: yes, 2018
Purpose To explore what the current worldwide preferred practice patterns of pediatric ophthalmologists are to decrease myopia progression among their patients.
Farzavandi, Sonal K.   +5 more
core   +1 more source

Prevention of Dermatologic Side Effects of Bimatoprost 0.03% Topical Therapy [PDF]

open access: yes, 2006
PURPOSE: To investigate the efficacy of reducing the drop-skin contact to prevent dermatologic side effects of bimatoprost 0.03% topical therapy. DESIGN: Prospective, randomized, single-blinded, internally controlled study.
Centofanti, M   +5 more
core   +2 more sources

Home - About - Disclaimer - Privacy